Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Shop Apotheke Europe NV buy Traumtanz

Start price
€98.00
20.05.20 / 50%
Target price
€200.00
20.08.20
Performance (%)
58.16%
End price
€155.00
20.08.20
Summary
This prediction ended on 20.08.20 with a price of €155.00. With a performance of 58.16% the BUY prediction by Traumtanz was a big success. Traumtanz has 50% into this prediction

Shop Apotheke Europe is a German-based online pharmacy that operates in the European market, offering a broad range of pharmaceutical products, health and wellness items, and beauty and personal care products. It provides customers with an easy-to-use platform to purchase goods, as well as convenient delivery options. Shop Apotheke Europe has continuously expanded its operations, including through several acquisitions, and has established itself as a leading player in the rapidly-growing market of online pharmacies. The company is listed on the Frankfurt Stock Exchange and has a market capitalization of over €1 billion.

Performance without dividends (%)
Name 1w 1m 1y 3y
Shop Apotheke Europe NV -1.821% -1.821% 50.346% -31.919%
iShares Core DAX® -1.670% -1.001% 10.864% 12.563%
iShares Nasdaq 100 -4.184% -1.145% 37.458% 41.078%
iShares Nikkei 225® -4.967% -5.783% 18.828% 0.655%
iShares S&P 500 -2.834% -0.572% 25.875% 39.960%

According to Traumtanz what are the pros and cons of Shop Apotheke Europe NV for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
Very differentiated customer and product portfolio
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Undervalued
Very valuable balance sheet
Strong uniques
Sustainability is very important
Rising EBIT margin expected
Top Rating
High Investments for future growth
ROE higher than 15% per year
Small challenges to pay loans and raise capital
Very capable Management
Very good company culture
Leading role in innovation
Growths much faster than the competition
Management is a major shareholder
Small Risks for its business
Very small cyclical dependencies
Cons

Comments by Traumtanz for this prediction

In the thread Shop Apotheke Europe NV diskutieren
Prediction Buy
Perf. (%) 58.16%
Target price 125.000
Change
Ends at 20.08.20

Buy mit Kursziel 125,0- erste Einschätzung bei gut 34€ abgegeben, real investiert.

zur Gewinnmitnahme geschlossen - Weiter positiv up!

Prediction Buy
Perf. (%) 58.16%
Target price 150.000
Change
Ends at 20.08.20

Kursziel geändert auf 150,0

Prediction Buy
Perf. (%) 58.16%
Target price 200.000
Change
Ends at 20.08.20

Kursziel geändert auf 200,0

In the thread Trading Shop Apotheke Europe NV
Prediction Buy
Perf. (%) 58.16%
Target price 200.000
Change
Ends at 20.08.20

Buy beendet

Stopped prediction by Traumtanz for Shop Apotheke Europe NV

buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€144.95
10.02.24
€147.00
10.02.25
5.07%
29.03.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€141.75
07.02.24
€144.00
07.02.25
2.26%
10.02.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€140.35
06.02.24
€142.00
06.02.25
1.00%
07.02.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€95.08
30.06.23
€100.00
30.06.24
2.40%
05.07.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€91.50
20.06.23
€95.00
20.06.24
3.91%
30.06.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€74.32
15.03.23
€78.00
15.03.24
-4.17%
24.03.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€69.96
07.03.23
€72.00
07.03.24
6.23%
15.03.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€68.94
16.02.23
€71.00
16.02.24
6.15%
04.03.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€64.60
13.02.23
€68.00
13.02.24
6.72%
16.02.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€63.42
09.02.23
€68.00
31.05.23
1.86%
13.02.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€102.90
31.05.22
€68.00
31.05.23
-38.37%
09.02.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€86.20
05.04.22
€100.00
01.09.22
19.37%
31.05.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€191.40
21.01.21
€200.00
4.49%
26.01.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€162.60
16.10.20
€175.00
04.11.21
8.86%
20.01.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€135.80
08.09.20
€175.00
16.10.20
20.03%
16.10.20

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€155.40
20.08.20
-
05.09.20
-18.92%
05.09.20

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€63.20
07.04.20
€100.00
20.05.20
55.06%
20.05.20

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€51.30
06.03.20
€85.00
07.04.20
23.20%
07.04.20

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€34.30
05.10.19
€55.00
06.03.20
53.35%
06.03.20

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected